1166. The Cost-Effectiveness Evidence of Enhanced Influenza Vaccines in Adults ≥65 Years of Age: A Literature Review and Decision-Making Implications

BACKGROUND: Older individuals have high rates of seasonal influenza-related hospitalizations and deaths. For this population, enhanced vaccines have been designed to mitigate the effect of age-related immunosenescence by providing higher immunogenicity and increased relative vaccine effectiveness (r...

Descripción completa

Detalles Bibliográficos
Autores principales: Giglio, David FismanNorberto, Márquez-Peláez, Sergio, Nguyen, Van, Postma, Maarten, Pugliese, Andrea, Ruiz-Aragón, Jesús, urueña, Analia, Mould-Quevedo, Joaquin F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679069/
http://dx.doi.org/10.1093/ofid/ofad500.1006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679069/
http://dx.doi.org/10.1093/ofid/ofad500.1006

Ejemplares similares